Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of November 2023, specifically dated November 3, 2023. The report serves as a notification of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them, in compliance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively details share purchase transactions by senior management.
Material Changes and Transactions
On November 3, 2023, three individuals purchased ordinary shares of Rentokil Initial plc on the London Stock Exchange (XLON). The transactions are summarized below:
| Individual | Position | Shares Purchased | Price per Share | Total Value |
|---|---|---|---|---|
| Andy Ransom | Chief Executive | 45,700 | £4.385034 | £200,396.05 |
| Richard Solomons | Chairman | 22,900 | £4.36334 | £99,920.49 |
| Caroline Ingall-Tombs | Associated with CFO | 22,904 | £4.376172 | £100,231.84 |
Total Shares Purchased: 91,504
Total Transaction Value: £400,548.38
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on business strategy, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of share ownership changes.
Investor Verification Checklist
- Verify the total number of shares purchased by the CEO, Chairman, and the CFO's associate on November 3, 2023.
- Confirm the average price per share paid by each individual to assess their valuation of the stock at that time.
- Check subsequent filings to determine if these purchases were part of a broader share buyback program or individual investment decisions.
- Note that this filing contains no operational or financial performance data for the period.